Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.
about
The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral LeishmaniasisRestoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterolLeishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterolCholesterol Corrects Altered Conformation of MHC-II Protein in Leishmania donovani Infected Macrophages: Implication in Therapy.Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.Cholesterol lowering drug may influence cellular immune response by altering MHC II function.Liposomal cholesterol delivery activates the macrophage innate immune arm to facilitate intracellular Leishmania donovani killing.The role of extracellular vesicles in Plasmodium and other protozoan parasites.Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis.Biochemical and nutritional evaluation of patients with visceral leishmaniasis before and after treatment with leishmanicidal drugs.Changes to cholesterol trafficking in macrophages by Leishmania parasites infection.Changes in Lipid and Fatty Acid Composition During Intramacrophagic Transformation of Leishmania donovani Complex Promastigotes into Amastigotes.Lipids: a key player in the battle between the host and microorganisms.
P2860
Q26752513-2CFA57B8-DFB4-4A67-8105-9121C389B489Q28476834-C374C573-D45C-4F60-9B81-FFC635B91D8BQ28542482-CFBA3D0B-194B-43C1-98BF-215F976E930AQ36026687-0655A2CA-6F21-486D-8E3C-7F03B791B75BQ36387245-20660C07-5218-4C21-BD68-32C1A5074D73Q36708313-764391CE-E9E2-4065-B584-64EB228F9812Q37222694-3C65BF97-B0F3-427B-A031-39E929A32A90Q37546471-7D632F49-FE64-4002-9067-45BAA98B3273Q37662612-9DC6C6DC-9886-4097-9766-553319957783Q40147973-9A2FCF56-A804-4291-A7EE-43E11DA1F877Q40219731-616361A8-E2CF-4C52-92E9-1C0EA063B170Q40275481-F6CAAA3A-200F-4FDB-B15C-D5D9D7EE10DFQ40345051-7135F4BF-E88C-4623-987B-39C44228C362Q41292718-682C6497-5E17-4426-9BC5-B56230B247E3
P2860
Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@ast
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@en
type
label
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@ast
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@en
prefLabel
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@ast
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@en
P2093
P2860
P1476
Human visceral leishmaniasis: ...... tion of splenic parasite load.
@en
P2093
K Roychoudhury
P2860
P304
P356
10.1179/136485911X12899838683566
P577
2011-04-01T00:00:00Z